• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Population-based risk factors and geographical trends identified for vitiligo

byAdam Whittington
July 16, 2014
in Chronic Disease, Dermatology
Reading Time: 2 mins read
Population-based risk factors and geographical trends identified for vitiligo
Share on FacebookShare on Twitter

1. Foreign born adults with vitiligo self-reported lower affected body surface area (BSA) when compared with native born US adults.

2. Either being born or having resided in regions closer to the equator appeared to be a positive prognostic factor for vitiligo extent.

Evidence Rating Level: 2 (Good)

Study Rundown: The pathogenesis of vitiligo, which is thought to result from immune-mediated attack of melanocytes, is relatively well studied. In contrast, little is known about the epidemiological risk and prognostic factors for the development of the disease and the extent of vitiligo BSA involvement, respectively. In this study, authors sought to identify trends in population-based risk factors and regional differences for vitiligo. After controlling for potentially confounding variables (e.g. race, sex, current age, and age at vitiligo onset), being born outside of the US, being born near the equator, or residing near the equator associated with a lower odds of vitiligo BSA greater than 25%. A strength of this study was the large and diverse sample size attained, though limitations did exist. One such limitation was a potential self-selection bias of the questionnaire respondents due to surveying vitiligo support groups.

Click to read the study in JAMA Dermatology

Relevant reading: Association between vitiligo extent and distribution and quality-of-life impairment

RELATED REPORTS

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

Long term phototherapy can enhance treatment response in vitiligo

Patient Basics: Vitiligo

In-Depth [prospective cohort]: Members from nonprofit support groups for vitiligo vulgaris were invited to participate in a 77-question survey, and 2786 responses were analyzed. Logistic regression models were built to determine effects of country of birthplace and present residence on BSA affected. To account for countries with few respondents, composite variables were created, and adjusted odds ratios were calculated for multivariate models. 72.2% of respondents currently resided in the US, and similarly, 62.8% of respondents reported a birthplace within the US. Individuals born outside the US had significantly lower odds of affected BSA > 25% (logistic regression; OR, 0.52 [95% CI, 0.44-0.61]; p < 0.001). This association remained significant, even in multivariate models (p < 0.001) and whether they currently lived inside (OR, 0.52 [95% CI, 0.4-0.67]; p < 0.001) or outside (OR, 0.52 [95% CI, 0.43-0.62]; p < 0.001) the United States. Individuals born or residing in regions with latitudes between -24 and 24 degrees were less likely to have affected BSA > 25% (birthplace: 7.1% vs 13.0%, p < 0.001; residence: 3.0% vs 5.5%, p = 0.002).

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: vitiligo
Previous Post

No benefit with hydroxychloroquine (Plaquenil) over placebo in Sjogren’s Syndrome [JOQUER Trial]

Next Post

Decreased facial expression variability linked with serious cardiac disease

RelatedReports

Afamelanotide plus UV-B phototherapy effective for vitiligo
Chronic Disease

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

October 21, 2022
Long term phototherapy can enhance treatment response in vitiligo
Chronic Disease

Long term phototherapy can enhance treatment response in vitiligo

April 7, 2017
Health A to Z

Patient Basics: Vitiligo

November 30, 2014
Vitiligo associated with lower incidence of skin cancers
Chronic Disease

Vitiligo associated with lower incidence of skin cancers

September 28, 2014
Next Post
Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)

Decreased facial expression variability linked with serious cardiac disease

No obesity paradox found between BMI, stroke, and death

Stroke within past 9 months linked with adverse surgical outcomes

Positive physician experience in the Pediatric AIDS Corps

New second-line antiretroviral regimens effective for HIV in resource-limited settings

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.